Hims & Hers Health (NYSE: HIMS)
Key Data Points
Hims & Hers Health Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Hims & Hers Health Company Info
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
News & Analysis
Why Hims & Hers Health Stock Couldn't Beat the Market Today
Why Hims & Hers Health Stock Soared Tuesday
Is Hims & Hers Stock Too Cheap to Pass Up?
This high-growth stock may be cheaper than you think.
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Why Hims & Hers Stock Tumbled on Tuesday
Bank of America just delivered an incredibly back-handed compliment to Hims & Hers stock.
Why Hims & Hers Stock Popped on Monday
Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock?
Why Hims & Hers Health Stock Just Popped
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
Shutting down an acquisition caught investor attention, but there's more to the story.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Podcast Episodes

Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

A New Name in Weight Loss Drugs
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.